-
Mashup Score: 1Webprogram Unavailable - 6 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Paper: Whole-Exome Sequencing Identifies a Somatic Cell Mutation Signature That Predicts Relapse Risk and Survival Probability in Multiple Myeloma - 6 month(s) ago
Program: Oral and Poster Abstracts Session: 651. Myeloma: Biology and Pathophysiology, excluding Therapy: Poster I Hematology Disease Topics & Pathways: multiple myeloma, Diseases, Technology and Procedures, Plasma Cell Disorders, Lymphoid Malignancies, Clinically relevant, genetic profiling 1 Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Shaker Hts, OH 2 Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 3 Institute
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Webprogram Unavailable - 6 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Webprogram Unavailable - 10 month(s) ago
Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Webprogram Unavailable - 10 month(s) ago
Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Webprogram Unavailable - 10 month(s) ago
Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Recommendation on Advanced Molecular Testing in Hematolymphoid Malignancies in the Veterans Population - 11 month(s) ago
Abstract. The Veterans Health Administration is the largest integrated provider of cancer services in the nation, with approximately 50,000 new cancer cases dia
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment - 11 month(s) ago
Abstract. Background: Multiple myeloma (MM) patients are immunocompromised due to defects in humoral/cellular immunity and immunosuppressive therapy. Reports in
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Evaluation of Functional and Cytogenetic High-Risk Multiple Myeloma Using Real-World Data - 1 year(s) ago
Abstract. Introduction: Multiple myeloma (MM) is a heterogeneous disease with wide variability in outcomes. The presence of cytogenetic abnormalities in MM is o
Source: American Society of HematologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Webprogram Unavailable - 1 year(s) ago
Webprogram is no longer available Please click HERE if you are not redirected in 5 seconds.
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
Impact of Chromosome 1 Abnormalities Among Pts w/ Newly Diagnosed Multiple Myeloma: A Subgroup Analysis from the Endurance (#EAonc E1A11) Trial [oral: 12/12/21] @TMSchmidtMD et al. @myelomaMD @eaonc Abstract 467 #ASH21 https://t.co/HaaZ5tEEPT #NCT01863550 #mmsm #PrecisionMedicine https://t.co/CAN5w5Mt1Y